CNYBAC Concept to Commercialization Virtual Series Presents: Building an Attractive Patent Portfolio while Postponing Costs for Small Life Science Companies

Building an Attractive Patent Portfolio while Postponing Costs for Small Life Science Companies 

Date September 8th 2022, 3:00 – 4:00 p.m. EST
Preben Rasmussen, PhD and Jakob Poulsen, PhD, VALUA ApS 

Register in advance for this meeting: 

https://upstate.zoom.us/meeting/register/tJckdOirrD8jHNI65jEyoOZtLPWPJs3TwSc1  

After registering, you will receive an email containing information about joining the meeting. 

The patent portfolio of smaller life science companies is often decisive for attracting capital. Building a patent portfolio often requires costs in the beginning of the application process, which may be problematic for smaller Life Science companies, because the establishment of a revenue stream may take several years.  

We will present ideas for making your patent portfolio attractive for potential investors while keeping costs down. The development of your patent portfolio will be closely linked to your scientific development program. The need for continuous pruning of the patent portfolio will be discussed.  

SPEAKER BIO 

Preben Rasmussen, Ph.D., European Patent Attorney. 

Preben has mainly worked within biotechnology and Life sciences, in particular within Molecular biology, patenting of enzymes, microorganisms and fermentation technology, and has further knowledge in the pharmaceutical area including patent term extensions such as SPCs. 

Preben has previously worked extensively with global IP strategies, building patent portfolios in several jurisdictions, including USA, Europe, China, Japan, Brazil and Australia.  

PhD obtained at the Laboratory of Microbiology, Technical University of Denmark. 

Master of Engineering, Technical University of Denmark. 

Jakob Poulsen, Ph.D., European Patent Attorney. 

Jakob carries experience from private practice as well as medium sized pharmaceutical companies, including both the generic and the originator industry. His experience comprises patent infringement litigation, legal opinions, due diligence and general patent work, such as drafting, prosecution, and opposition work. Focus has been on building patent protection in the US, Europe, Japan, Canada, Australia and New Zealand. 

Jakob has in particular experience within Life Science (working with pharmaceuticals, chemistry and biotechnology), as well as software related inventions. 

Ph.D. Solid State Chemistry, Kyoto University, Japan 

M.Sc. Physics-Chemistry, Aarhus University, Denmark